Screener
ANI Pharmaceuticals ANIP Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryGross.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
FAQ
- What is ANI Pharmaceuticals's inventories?
- ANI Pharmaceuticals (ANIP) reported inventories of $143.15M in Q2 2026.
- How has ANI Pharmaceuticals's inventories changed year-over-year?
- ANI Pharmaceuticals's inventories increased by 3.5% year-over-year, from $138.32M to $143.15M.
- What is the long-term trend for ANI Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's inventories has grown at a 18.7% compound annual growth rate (CAGR), from $60.8M to $143.07M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about ANI Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude